Impact of serological and PCR testing requirements on the selection of COVID ‐19 convalescent plasma donors

Autor: Alex T Freedenberg, Margaret E Shevik, Tahmeena Ahmed, Nicholas J Browne, Giuseppina A Caravella, Elliott Bennett-Guerrero, Laura M Generale, Megan E. Cosgrove, Jason A. Carter, Linda J Mamone, Lillian R Talbot, Molly G Rago, Jamie L. Romeiser
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Transfusion
ISSN: 1537-2995
0041-1132
DOI: 10.1111/trf.16293
Popis: Background Convalescent plasma is undergoing randomized trials as a potential therapeutic option for COVID‐19 infection. Little empirical evidence exists regarding the determination of donor eligibility and experiences with donor selection. Study Design and Methods This prospective study was conducted at a tertiary care hospital in New York to select plasma donors for a randomized, double‐blind, controlled convalescent plasma trial. Clearance for donation required successful completion of an online questionnaire and an in‐person screening visit, which included (a) completion of a Donor Health Questionnaire (DHQ), (b) Immunoglobulin G (IgG) antibody testing using an immunochromatographic anti‐ severe acute respiratory coronavirus 2 (SARS‐CoV‐2) test, (c) Polymerase chain reaction (PCR) testing if
Databáze: OpenAIRE